Aquis Exchange Valuation
Is A9Q undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of A9Q when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: A9Q (€8.35) is trading above our estimate of fair value (€4.08)
Significantly Below Fair Value: A9Q is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for A9Q?
Key metric: As A9Q is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is A9Q's PE Ratio? | |
|---|---|
| PE Ratio | 37.5x |
| Earnings | UK£4.97m |
| Market Cap | UK£186.21m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.3x |
| Enterprise Value/EBITDA | 34.2x |
| PEG Ratio | 3.5x |
Price to Earnings Ratio vs Peers
How does A9Q's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 13.7x | ||
HXCK Ernst Russ | 3.8x | -18.2% | €199.4m |
O4B OVB Holding | 15.1x | 3.8% | €279.3m |
BWB Baader Bank | 15.3x | n/a | €199.6m |
QB7 Quirin Privatbank | 20.7x | n/a | €167.6m |
A9Q Aquis Exchange | 37.5x | 10.6% | €186.2m |
Price-To-Earnings vs Peers: A9Q is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the peer average (13.7x).
Price to Earnings Ratio vs Industry
How does A9Q's PE Ratio compare vs other companies in the DE Capital Markets Industry?
| 4 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|---|---|---|
AR4 AURELIUS Equity Opportunities SE KGaA | 3.8x | n/a | US$405.06m |
HXCK Ernst Russ | 3.8x | -18.2% | US$209.96m |
VG8 Varengold Bank | 2x | n/a | US$26.85m |
XE8 Black Sea Property | 0.7x | n/a | US$7.76m |
| 4 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: A9Q is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the German Capital Markets industry average (20.7x).
Price to Earnings Ratio vs Fair Ratio
What is A9Q's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 37.5x |
| Fair PE Ratio | 15x |
Price-To-Earnings vs Fair Ratio: A9Q is expensive based on its Price-To-Earnings Ratio (37.5x) compared to the estimated Fair Price-To-Earnings Ratio (15x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | €8.35 | €9.51 +13.9% | 21.9% | €11.59 | €7.43 | n/a | 2 |
| Nov ’25 | €3.80 | €9.54 +151.1% | 17.8% | €11.38 | €7.29 | n/a | 3 |
| Oct ’25 | €4.24 | €9.54 +125.0% | 17.8% | €11.38 | €7.29 | n/a | 3 |
| Sep ’25 | €4.46 | €9.55 +114.1% | 17.8% | €11.39 | €7.30 | n/a | 3 |
| Aug ’25 | €5.75 | €9.92 +72.5% | 12.0% | €11.39 | €8.48 | n/a | 3 |
| Jul ’25 | €5.40 | €9.92 +83.7% | 12.0% | €11.39 | €8.48 | n/a | 3 |
| Jun ’25 | €5.35 | €9.82 +83.5% | 12.0% | €11.27 | €8.39 | n/a | 3 |
| May ’25 | €5.30 | €9.82 +85.2% | 12.0% | €11.27 | €8.39 | n/a | 3 |
| Apr ’25 | €4.44 | €9.82 +121.1% | 12.0% | €11.27 | €8.39 | n/a | 3 |
| Mar ’25 | €4.10 | €10.03 +144.6% | 13.7% | €11.79 | €8.44 | n/a | 3 |
| Feb ’25 | €4.16 | €10.03 +141.0% | 13.7% | €11.79 | €8.44 | n/a | 3 |
| Jan ’25 | €4.08 | €9.83 +140.9% | 13.5% | €11.54 | €8.32 | n/a | 3 |
| Dec ’24 | €3.88 | €9.83 +153.4% | 13.5% | €11.54 | €8.32 | n/a | 3 |
| Nov ’24 | €3.84 | €9.83 +156.0% | 13.5% | €11.54 | €8.32 | €3.80 | 3 |
| Oct ’24 | €4.08 | €9.92 +143.1% | 11.6% | €11.60 | €8.36 | €4.24 | 4 |
| Sep ’24 | €4.04 | €9.88 +144.4% | 11.7% | €11.56 | €8.32 | €4.46 | 4 |
| Aug ’24 | €4.36 | €9.88 +126.5% | 11.7% | €11.56 | €8.32 | €5.75 | 4 |
| Jul ’24 | €4.34 | €9.88 +127.5% | 11.7% | €11.56 | €8.32 | €5.40 | 4 |
| Jun ’24 | €4.66 | €9.88 +111.9% | 11.7% | €11.56 | €8.32 | €5.35 | 4 |
| May ’24 | €4.50 | €10.28 +128.5% | 8.1% | €11.44 | €9.53 | €5.30 | 3 |
| Apr ’24 | €4.24 | €10.02 +136.2% | 8.6% | €11.45 | €9.18 | €4.44 | 4 |
| Mar ’24 | €4.36 | €10.07 +130.9% | 9.5% | €11.69 | €9.25 | €4.10 | 4 |
| Feb ’24 | €4.16 | €10.07 +142.0% | 9.5% | €11.69 | €9.25 | €4.16 | 4 |
| Jan ’24 | €4.14 | €10.07 +143.2% | 9.5% | €11.69 | €9.25 | €4.08 | 4 |
| Dec ’23 | €4.78 | €10.07 +110.6% | 9.5% | €11.69 | €9.25 | €3.88 | 4 |
| Nov ’23 | €3.42 | €10.07 +194.4% | 9.5% | €11.69 | €9.25 | €3.84 | 4 |
Analyst Forecast: Target price is less than 20% higher than the current share price.
Discover undervalued companies
Merchants Bancorp
US$1.8b
Operates as the diversified bank holding company in the United States.
3KD
US$38.00
7D
3.8%
1Y
25.8%
Exor
€20.1b
Engages in the luxury goods, automotive, agricultural and construction equipment, commercial vehicles, and professional football businesses worldwide.
EYX
€94.05
7D
-1.6%
1Y
10.8%
Mutares SE KGaA
€456.9m
A private equity firm specializing in investments in secondary direct, special situations, bridge financing, recapitalization, distressed/vulture, management succession, reorganization, carve-outs, turnarounds, spin-offs and re-funding.
MUX
€22.15
7D
-2.9%
1Y
-32.5%